Paul Matteis
Stock Analyst at Stifel Nicolaus
(4.85)
# 384
Out of 4,517 analysts
709
Total ratings
54.2%
Success rate
19.3%
Average return
Main Sectors:
Stocks Rated by Paul Matteis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals | Maintained: Buy | $444 | $281.54 | +57.70% | 47 | Jul 14, 2026 | |
| BIIB Biogen | Maintained: Buy | $214 | $207.94 | +2.91% | 51 | Jul 14, 2026 | |
| DFTX Definium Therapeutics | Rated: Buy | $30 → $60 | $43.72 | +37.24% | 5 | Jul 8, 2026 | |
| CMPS COMPASS Pathways | Rated: Buy | $14 → $21 | $12.37 | +69.77% | 7 | Jul 8, 2026 | |
| NGNE Neurogene | Maintained: Buy | $46 | $36.50 | +26.03% | 24 | Jul 6, 2026 | |
| VTGN Vistagen Therapeutics | Maintained: Hold | $1 | $0.2378 | +320.52% | 8 | Jul 6, 2026 | |
| LXEO Lexeo Therapeutics | Maintained: Buy | $17 | $4.56 | +272.81% | 9 | Jul 6, 2026 | |
| QURE uniQure | Maintained: Buy | $28 → $71 | $39.60 | +79.29% | 26 | Jun 21, 2026 | |
| RYTM Rhythm Pharmaceuticals | Reiterated: Buy | $133 | $106.10 | +25.35% | 12 | Jun 15, 2026 | |
| SPTX Seaport Therapeutics | Reiterated: Buy | $30 | $19.41 | +54.56% | 2 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $36 | $36.36 | -0.99% | 4 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $14.98 | +66.94% | 3 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 | $46.18 | +19.10% | 4 | May 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $68 | $59.81 | +13.69% | 44 | May 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 | $1.61 | +86.34% | 10 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $56 | $39.40 | +42.12% | 10 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 → $45 | $52.60 | -14.45% | 57 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $89 → $86 | $66.55 | +29.23% | 27 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 → $28 | $13.95 | +100.72% | 10 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $24 | $25.68 | -6.54% | 48 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $188 | $172.18 | +9.19% | 54 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $466 | $484.70 | -3.86% | 41 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $83 → $86 | $54.47 | +57.89% | 32 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $2.25 | +433.33% | 17 | Apr 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $27.18 | +21.41% | 10 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $41 | $22.49 | +82.30% | 28 | Mar 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $40 | $30.63 | +30.59% | 3 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $28.32 | +12.99% | 10 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.44 | - | 12 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $2.15 | +365.12% | 9 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $39 → $36 | $22.61 | +59.22% | 26 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.40 | n/a | 11 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $12.16 | n/a | 11 | Jun 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $5.65 | n/a | 13 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $11 → $20 | $74.21 | n/a | 4 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $0.0001 | n/a | 1 | Aug 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $20 | $0.0001 | n/a | 4 | Mar 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.18 | n/a | 1 | Nov 23, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.78 | n/a | 4 | Jun 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $16.98 | n/a | 5 | Jun 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $0.0001 | n/a | 3 | May 19, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 → $7 | $0.96715 | n/a | 2 | May 6, 2016 |
Alnylam Pharmaceuticals
Jul 14, 2026
Maintained: Buy
Price Target: $444
Current: $281.54
Upside: +57.70%
Biogen
Jul 14, 2026
Maintained: Buy
Price Target: $214
Current: $207.94
Upside: +2.91%
Definium Therapeutics
Jul 8, 2026
Rated: Buy
Price Target: $30 → $60
Current: $43.72
Upside: +37.24%
COMPASS Pathways
Jul 8, 2026
Rated: Buy
Price Target: $14 → $21
Current: $12.37
Upside: +69.77%
Neurogene
Jul 6, 2026
Maintained: Buy
Price Target: $46
Current: $36.50
Upside: +26.03%
Vistagen Therapeutics
Jul 6, 2026
Maintained: Hold
Price Target: $1
Current: $0.2378
Upside: +320.52%
Lexeo Therapeutics
Jul 6, 2026
Maintained: Buy
Price Target: $17
Current: $4.56
Upside: +272.81%
uniQure
Jun 21, 2026
Maintained: Buy
Price Target: $28 → $71
Current: $39.60
Upside: +79.29%
Rhythm Pharmaceuticals
Jun 15, 2026
Reiterated: Buy
Price Target: $133
Current: $106.10
Upside: +25.35%
Seaport Therapeutics
Jun 9, 2026
Reiterated: Buy
Price Target: $30
Current: $19.41
Upside: +54.56%
Jun 2, 2026
Reiterated: Buy
Price Target: $28 → $36
Current: $36.36
Upside: -0.99%
May 28, 2026
Maintained: Buy
Price Target: $25
Current: $14.98
Upside: +66.94%
May 25, 2026
Maintained: Buy
Price Target: $55
Current: $46.18
Upside: +19.10%
May 24, 2026
Maintained: Hold
Price Target: $68
Current: $59.81
Upside: +13.69%
May 12, 2026
Maintained: Hold
Price Target: $3
Current: $1.61
Upside: +86.34%
May 12, 2026
Maintained: Buy
Price Target: $56
Current: $39.40
Upside: +42.12%
May 8, 2026
Maintained: Buy
Price Target: $42 → $45
Current: $52.60
Upside: -14.45%
May 8, 2026
Maintained: Buy
Price Target: $89 → $86
Current: $66.55
Upside: +29.23%
May 8, 2026
Maintained: Buy
Price Target: $29 → $28
Current: $13.95
Upside: +100.72%
May 7, 2026
Reiterated: Hold
Price Target: $24
Current: $25.68
Upside: -6.54%
May 6, 2026
Maintained: Buy
Price Target: $188
Current: $172.18
Upside: +9.19%
May 5, 2026
Maintained: Hold
Price Target: $466
Current: $484.70
Upside: -3.86%
Apr 30, 2026
Maintained: Hold
Price Target: $83 → $86
Current: $54.47
Upside: +57.89%
Apr 4, 2026
Maintained: Buy
Price Target: $12
Current: $2.25
Upside: +433.33%
Apr 2, 2026
Maintained: Buy
Price Target: $33
Current: $27.18
Upside: +21.41%
Mar 29, 2026
Maintained: Buy
Price Target: $41
Current: $22.49
Upside: +82.30%
Mar 27, 2026
Reiterated: Buy
Price Target: $35 → $40
Current: $30.63
Upside: +30.59%
Mar 6, 2026
Reiterated: Buy
Price Target: $32
Current: $28.32
Upside: +12.99%
Dec 22, 2025
Rated: Hold
Price Target: n/a
Current: $1.44
Upside: -
Dec 16, 2025
Reiterated: Buy
Price Target: $10
Current: $2.15
Upside: +365.12%
Dec 15, 2025
Maintained: Buy
Price Target: $39 → $36
Current: $22.61
Upside: +59.22%
Sep 19, 2024
Rated: Hold
Price Target: n/a
Current: $7.40
Upside: n/a
Jun 3, 2023
Maintained: Buy
Price Target: $5
Current: $12.16
Upside: n/a
May 12, 2022
Reiterated: Hold
Price Target: $3
Current: $5.65
Upside: n/a
Feb 28, 2022
Downgraded: Hold
Price Target: $11 → $20
Current: $74.21
Upside: n/a
Aug 16, 2017
Initiated Coverage: Buy
Price Target: $18
Current: $0.0001
Upside: n/a
Mar 10, 2017
Reiterated: Buy
Price Target: $14 → $20
Current: $0.0001
Upside: n/a
Nov 23, 2016
Reiterated: Buy
Price Target: n/a
Current: $2.18
Upside: n/a
Jun 20, 2016
Reiterated: Buy
Price Target: n/a
Current: $2.78
Upside: n/a
Jun 20, 2016
Reiterated: Buy
Price Target: $29
Current: $16.98
Upside: n/a
May 19, 2016
Maintained: Buy
Price Target: $11
Current: $0.0001
Upside: n/a
May 6, 2016
Reiterated: Hold
Price Target: $14 → $7
Current: $0.96715
Upside: n/a